Skip to content

Detection of early breast cancer by peptide mass spectrometry (BLOTCHIP(R)-MS method)

Detection of early breast cancer by peptide mass spectrometry (BLOTCHIP(R)-MS method) - Detection of early breast cancer by BLOTCHIP(R)-MS method

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025295
Enrollment
100
Registered
2016-12-15
Start date
2017-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Kyoto Prefectural University of Medicine
Lead Sponsor
Protosera Inc.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Breast cancer patients 2. Cases without breast cancer as a control group

Exclusion criteria

Exclusion criteria: 1. Pregnant 2. Pretreated patient 3. Double cancer 4. Unqualified patient

Design outcomes

Primary

MeasureTime frame
Accuracy of breast cancer diagnosis of serum peptide biomarker identified by peptide mass spectrometry

Secondary

MeasureTime frame
Correlation with breast cancer clinical stage, tumor marker, therapeutic significance of identified peptide markers

Countries

Japan

Contacts

Public ContactKoichi Sakaguchi

Kyoto Prefectural University of Medicine Department of Endocrine and Breast Surgery

ksak@koto.kpu-m.ac.jp075-251-5534

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026